NCT00266188

Brief Summary

Tetralogy of Fallot is the most frequent complex congenital heart malformation. Over the past five decades, surgical repair has been performed with respectable results. However, relevant postoperative residues frequently remain. Pulmonary insufficiency, in particular, has been identified as a factor limiting the right ventricular function and, accordingly, the quality of life and life expectancy. With increasing use of cardiac MRI for both measurement of ventricular function and imaging of pulmonary arteries, residual defects have been discovered that were not detectable by echocardiography. There is mounting evidence of right ventricular pressure and volume stress in Fallot patients after surgical correction. At present, it is impossible to detect right ventricular insufficiency at an early stage. Hence, it is to be assumed that right ventricular insufficiency is underdiagnosed and therapeutic action frequently is initiated beyond the point of no return of ventricular function. The objective of this study is the systematic collection of cross-sectional and longitudinal data from extensive standardised examinations, including MRI, echocardiography, pulmonary function and ergometry tests, ECG and quality of life assessments, in a large number of patients with surgically corrected tetralogy of Fallot, and the setup of a database. The data obtained are supposed to provide information on the long-term outcome of surgical correction, to help establish criteria for necessity and time of re-intervention or re-operation, and to assess the effectiveness of re-interventions and re-operations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
406

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2005

Typical duration for all trials

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2005

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

December 15, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2005

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2008

Completed
Last Updated

September 21, 2011

Status Verified

September 1, 2011

First QC Date

December 15, 2005

Last Update Submit

September 20, 2011

Conditions

Keywords

Heart Defects, CongenitalTetralogy of FallotHeart Septal Defects, VentricularPulmonary Valve DiseasesMagnetic Resonance ImagingHeart CatheterizationEchocardiography

Outcome Measures

Primary Outcomes (6)

  • - Assessment of the biventricular function via MRI, colour Doppler echocardiography, tissue Doppler and strain-rate imaging in correlation with objective exercise tolerance

  • (spiroergometry)

  • - Subjective quality of life

  • - Prevalence of cardiac dysrhythmias

  • - Mortality (above all in relapse interventions, such as interventional cardiac catheter or operation)

  • - Morbidity (i. e. severe unwanted effects [SUE], particularly in relapse interventions, such as interventional cardiac catheter or operation)

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient with tetralogy of Fallot

You may qualify if:

  • Written consent of the patient and/or the patient's legal representative
  • Patients with tetralogy of Fallot (including pulmonary atresia with extreme form of VSD ) after corrective operation
  • Ergospirometry and MRI examination can be carried out on an outpatient basis (i. e. patients are normally older than 8 years)
  • Patients are not selected according to functional status, i. e. in terms of potentially necessary reintervention measures (e. g. cardiac catheter intervention, pulmonary valve replacement)

You may not qualify if:

  • Lack of consent
  • Tetralogy of Fallot or pulmonary atresia with VSD without corrective operation (or corrective operation that dates back to less than one year before)
  • Pulmonary valve agenesia, DORV (if there is a distinct discontinuity between mitral valve and aortic valve)
  • Associated severe heart defects (e. g. AV canal)
  • Other clinically relevant diseases, such as malignant tumour or florid diseases (in the investigating physician's assessment)
  • Patient is not able to perform ergospirometry (bicycle/treadmill) or contraindication exists
  • Absolute MRI contraindication, e.g. cardiac pacemaker
  • Pregnant and breast-feeding patients
  • Lack of cardiac catheter findings (or MRI) before initial operation -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Universitätsklinikum Tübingen

Tübingen, Baden-Wurttemberg, D-72076, Germany

Location

Deutsches Herzzentrum Muenchen

Munich, Bavaria, D-80636, Germany

Location

Herzzentrum Hamburg, UKE

Hamburg, Hamburg, D-29246, Germany

Location

Medizinische Hochschule Hannover

Hanover, Lower Saxony, D-30625, Germany

Location

Universitätsklinikum RWTH Aachen

Aachen, North Rhine-Westphalia, D-52057, Germany

Location

Herz-und Diabeteszentrum Nordrhein-Westfalen

Bad Oeynhausen, North Rhine-Westphalia, D-32545, Germany

Location

Herzzentrum Duisburg

Duisburg, North Rhine-Westphalia, D-47137, Germany

Location

Universitätsklinikum Essen

Essen, North Rhine-Westphalia, D-45122, Germany

Location

Universitätsklinikum Schleswig-Holstein Campus Kiel

Kiel, North Rhine-Westphalia, D-24105, Germany

Location

Universitätsklinikum Muenster

Münster, North Rhine-Westphalia, D-48149, Germany

Location

Deutsches Kinderherzzentrum

Sankt Augustin, North Rhine-Westphalia, D-53757, Germany

Location

Herzzentrum Leipzig

Leipzig, Saxony, D-04289, Germany

Location

Deutsches Herzzentrum Berlin

Berlin, State of Berlin, D-13353, Germany

Location

Universitätsklinikum Charité

Berlin, State of Berlin, D-13353, Germany

Location

Related Publications (9)

  • Sarikouch S, Koerperich H, Dubowy KO, Boethig D, Boettler P, Mir TS, Peters B, Kuehne T, Beerbaum P; German Competence Network for Congenital Heart Defects Investigators. Impact of gender and age on cardiovascular function late after repair of tetralogy of Fallot: percentiles based on cardiac magnetic resonance. Circ Cardiovasc Imaging. 2011 Nov;4(6):703-11. doi: 10.1161/CIRCIMAGING.111.963637. Epub 2011 Sep 9.

  • Mueller M, Rentzsch A, Hoetzer K, Raedle-Hurst T, Boettler P, Stiller B, Lemmer J, Sarikouch S, Beerbaum P, Peters B, Vogt M, Vogel M, Abdul-Khaliq H. Assessment of interventricular and right-intraventricular dyssynchrony in patients with surgically repaired tetralogy of Fallot by two-dimensional speckle tracking. Eur J Echocardiogr. 2010 Oct;11(9):786-92. doi: 10.1093/ejechocard/jeq067. Epub 2010 May 30.

  • Riesenkampff E, Mengelkamp L, Mueller M, Kropf S, Abdul-Khaliq H, Sarikouch S, Beerbaum P, Hetzer R, Steendijk P, Berger F, Kuehne T. Integrated analysis of atrioventricular interactions in tetralogy of Fallot. Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H364-71. doi: 10.1152/ajpheart.00264.2010. Epub 2010 May 21.

  • Beerbaum P, Barth P, Kropf S, Sarikouch S, Kelter-Kloepping A, Franke D, Gutberlet M, Kuehne T. Cardiac function by MRI in congenital heart disease: impact of consensus training on interinstitutional variance. J Magn Reson Imaging. 2009 Nov;30(5):956-66. doi: 10.1002/jmri.21948.

  • Bodhey NK, Beerbaum P, Sarikouch S, Kropf S, Lange P, Berger F, Anderson RH, Kuehne T. Functional analysis of the components of the right ventricle in the setting of tetralogy of Fallot. Circ Cardiovasc Imaging. 2008 Sep;1(2):141-7. doi: 10.1161/CIRCIMAGING.108.783795. Epub 2008 Jul 30.

  • Diller GP, Vahle J, Radke R, Vidal MLB, Fischer AJ, Bauer UMM, Sarikouch S, Berger F, Beerbaum P, Baumgartner H, Orwat S; German Competence Network for Congenital Heart Defects Investigators. Utility of deep learning networks for the generation of artificial cardiac magnetic resonance images in congenital heart disease. BMC Med Imaging. 2020 Oct 8;20(1):113. doi: 10.1186/s12880-020-00511-1.

  • Orwat S, Diller GP, Kempny A, Radke R, Peters B, Kuhne T, Boethig D, Gutberlet M, Dubowy KO, Beerbaum P, Sarikouch S, Baumgartner H; German Competence Network for Congenital Heart Defects Investigators. Myocardial deformation parameters predict outcome in patients with repaired tetralogy of Fallot. Heart. 2016 Feb;102(3):209-15. doi: 10.1136/heartjnl-2015-308569. Epub 2015 Dec 29.

  • Sarikouch S, Boethig D, Peters B, Kropf S, Dubowy KO, Lange P, Kuehne T, Haverich A, Beerbaum P; Investigators of the German Competence Network for Congenital Heart Defects. Poorer right ventricular systolic function and exercise capacity in women after repair of tetralogy of fallot: a sex comparison of standard deviation scores based on sex-specific reference values in healthy control subjects. Circ Cardiovasc Imaging. 2013 Nov;6(6):924-33. doi: 10.1161/CIRCIMAGING.112.000195. Epub 2013 Oct 16.

  • Kutty S, Kuehne T, Gribben P, Reed E, Li L, Danford DA, Beerbaum PB, Sarikouch S. Ascending aortic and main pulmonary artery areas derived from cardiovascular magnetic resonance as reference values for normal subjects and repaired tetralogy of Fallot. Circ Cardiovasc Imaging. 2012 Sep 1;5(5):644-51. doi: 10.1161/CIRCIMAGING.112.973073. Epub 2012 Jun 22.

MeSH Terms

Conditions

Tetralogy of FallotHeart Defects, CongenitalHeart Septal Defects, Ventricular

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeart Septal Defects

Study Officials

  • Samir Sarikouch, MD

    Heart and Diabetes Center North Rhine-Westphalia

    PRINCIPAL INVESTIGATOR
  • Philipp Beerbaum, MD

    Kings College London, Division of Imaging Sciences

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

December 15, 2005

First Posted

December 16, 2005

Study Start

January 1, 2005

Study Completion

June 1, 2008

Last Updated

September 21, 2011

Record last verified: 2011-09

Locations